Search Results - "Lachnit, Martin"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis

    Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis by Lachnit, Martin, Revendova, Kamila Zondra, Hradilek, Pavel, Bunganic, Radovan, Koristek, Zdenek, Jelinek, Tomas, Skutova, Monika, Piza, Radim, Volny, Ondrej, Hajek, Roman, Bar, Michal

    “…Introduction. Immunoablative therapy followed by autologous hematopoietic stem cell transplantation (AHSCT) is one of the possible disease-modifying therapies…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    The Role of miR-126 in Critical Limb Ischemia Treatment Using Adipose-Derived Stem Cell Therapeutic Factor Concentrate and Extracellular Matrix Microparticles

    The Role of miR-126 in Critical Limb Ischemia Treatment Using Adipose-Derived Stem Cell Therapeutic Factor Concentrate and Extracellular Matrix Microparticles by Procházka, Václav, Jurčíková, Jana, Vítková, Kateřina, Pavliska, Lubomír, Porubová, Ludmila, Lassák, Ondrej, Buszman, Piotr, Fernandez, Carlos A, Jalůvka, František, Špačková, Iveta, Lochman, Ivo, Procházka, Martin, Janíková, Mária, Tauber, Zdeněk, Franková, Jana, Lachnit, Martin, Hiles, Michael C, Johnstone, Brian H

    Published in Medical science monitor (26-01-2018)
    “…BACKGROUND Paracrine factors secreted by adipose-derived stem cells can be captured, fractionated, and concentrated to produce therapeutic factor concentrate…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: